基质金属蛋白酶及其抑制物在宫颈癌表达的意义(2)
第1页 |
参见附件(2635KB,3页)。
[4] Liotta LA,Steeg PS and Stetler-Stevenson WG:Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation[J].Cell 1991,64:327-336.
[5] Crawford HC and Matrisian LM:Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.Invasion Metastasis,1994,14:234-245.
[6] Freije JM,Balbin M,Pendas AM,Sanchez LM,Puente XS and Lopez-Otin C:Matrix metalloproteinases and tumour progression.Adv Exp Med Biol, 2003,532:91-107.
[7] 吴丹,李珊珊,张红燕,等.宫颈鳞癌组织中E一钙粘附素的表达[J].郑州大学学报(医学版),2004,39(3):373-375.
[8] Grancotti FG,Ruoslahti E.Integrin Signaling F[J].Science,1999,285:1028-1033.
[9] 0beIgA,HoyhtyaM,Tavehn B,et.Limited value of preoperative senrum analyses of matrix metaUoproteinases(MMP-2,MMP-9)and tissue inbitors of matrix metaUoproteinases(TIMP-1,TIMP-2)in colorectal callcer [J].Anticancer Res,2OOO,20(2B):1085-1091.
[10] Murphy AN,Unsworth EJ,Stetler-Stevenson WG.Tissue inhibitor of metaUoproteinase-2 inhibits bFGF-induced human microvascular endo- thehal cell proliferation[J].J cell Physiol,1993,157(2):351-358.
[11] Kugler A.Matrix metalloproteinases and their inhibitors.Anti-cancer Res,1999,19(2C):1589-1592.
您现在查看是摘要介绍页,详见PDF附件(2635KB,3页)。